Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma

BACKGROUND: Several studies on the use of erythropoietin (Epo) to treat anaemia in patients undergoing cancer treatment have shown adverse effects on tumour control and survival. Experimental studies indicate that this could be linked to an interaction with wound healing processes and not an effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgren, Gustaf, Ekblad, Lars, Vallon-Christersson, Johan, Kjellén, Elisabeth, Gebre-Medhin, Maria, Wennerberg, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169800/
https://www.ncbi.nlm.nih.gov/pubmed/25182342
http://dx.doi.org/10.1186/1471-2407-14-648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169800/
https://www.ncbi.nlm.nih.gov/pubmed/25182342
http://dx.doi.org/10.1186/1471-2407-14-648

Ejemplares similares